Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances
Open Access
- 1 July 2017
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 23 (7) , 1193-1202
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Multiple MyelomaNew England Journal of Medicine, 2011
- Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantationBritish Journal of Haematology, 2009
- International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantationLeukemia, 2009
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersLeukemia, 2008
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple MyelomaNew England Journal of Medicine, 2008
- Eliminating the complete response penalty from myeloma response assessmentBlood, 2008
- A Comparison of Allografting with Autografting for Newly Diagnosed MyelomaNew England Journal of Medicine, 2007
- International uniform response criteria for multiple myelomaLeukemia, 2006
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATIONBritish Journal of Haematology, 1998